TONIX PHARMACEUTICALS HOLDING CORP. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $7.17 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-11
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $2.48M, a 9.36% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $4.69M, a 0.51% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $3.90M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $5.24M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $16.59M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$24.17M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$392.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$15.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 79 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 82 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $7.17M 10-Q · filed 2017-08-11 | $11.07M derived: sum of 3 quarters · filed 2017-08-11 | $16.31M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2017-03-31 | $4.69M 10-Q · filed 2017-05-12 | $8.60M derived: sum of 2 quarters · filed 2017-05-12 | $13.84M derived: sum of 3 quarters · filed 2017-05-12 | $16.57M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $9.14M derived: sum of 2 quarters · filed 2017-04-13 | $11.88M derived: sum of 3 quarters · filed 2017-08-11 | $16.59M 10-K · filed 2017-04-13 | ||
| 2016-09-30 | $5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $7.97M derived: sum of 2 quarters · filed 2017-08-11 | $12.69M 10-Q · filed 2016-11-10 | $10.77M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $7.45M 10-Q · filed 2017-08-11 | $5.53M derived: sum of 3 quarters · filed 2017-08-11 | -$16.57M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | $4.72M 10-Q · filed 2017-05-12 | $2.79M derived: sum of 2 quarters · filed 2017-05-12 | -$19.30M derived: sum of 3 quarters · filed 2017-05-12 | -$19.45M derived: sum of 4 quarters · filed 2017-05-12 | ||
| 2015-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | -$24.02M derived: sum of 2 quarters · filed 2017-04-13 | -$24.17M derived: sum of 3 quarters · filed 2017-04-13 | -$24.17M 10-K · filed 2017-04-13 | ||
| 2015-09-30 | -$22.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$22.25M derived: sum of 2 quarters · filed 2016-11-10 | -$22.25M 10-Q · filed 2016-11-10 | -$22.37M derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | -$153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$153.00K 10-Q · filed 2016-08-05 | -$278.00K derived: sum of 3 quarters · filed 2016-08-05 | -$438.00K derived: sum of 4 quarters · filed 2016-08-05 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-06 | -$125.00K derived: sum of 2 quarters · filed 2016-05-06 | -$285.00K derived: sum of 3 quarters · filed 2016-05-06 | -$390.00K derived: sum of 4 quarters · filed 2016-05-06 | ||
| 2014-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$285.00K derived: sum of 2 quarters · filed 2016-03-03 | -$390.00K derived: sum of 3 quarters · filed 2016-03-03 | -$392.00K 10-K · filed 2016-03-03 | ||
| 2014-09-30 | -$160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$265.00K derived: sum of 2 quarters · filed 2015-11-06 | -$267.00K 10-Q · filed 2015-11-06 | -$274.00K derived: sum of 4 quarters · filed 2016-03-03 | ||
| 2014-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$107.00K 10-Q · filed 2015-08-07 | -$114.00K derived: sum of 3 quarters · filed 2016-03-03 | -$122.00K derived: sum of 4 quarters · filed 2016-03-03 | ||
| 2014-03-31 | -$2.00K 10-Q · filed 2015-05-08 | -$9.00K derived: sum of 2 quarters · filed 2016-03-03 | -$17.00K derived: sum of 3 quarters · filed 2016-03-03 | -$17.00K derived: sum of 4 quarters · filed 2016-03-03 | -$156.00K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$15.00K derived: sum of 2 quarters · filed 2016-03-03 | -$15.00K derived: sum of 3 quarters · filed 2016-03-03 | -$15.00K 10-K · filed 2016-03-03 | -$154.00K 10-K · filed 2014-03-28 | |
| 2013-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$8.00K derived: sum of 2 quarters · filed 2014-11-07 | -$8.00K 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-13 | |||||
| 2012-12-31 | -$36.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |